Concord Medical Services Holdings Limited
CCM
$7.72
-$0.48-5.85%
NYSE
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -34.45% | -33.93% | -24.08% | 85.92% | 82.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.45% | -33.93% | -24.08% | 85.92% | 82.98% |
| Cost of Revenue | -30.34% | -29.78% | -26.58% | 30.25% | 28.20% |
| Gross Profit | 3.77% | 3.01% | 39.44% | 60.24% | 60.87% |
| SG&A Expenses | 42.04% | 43.17% | -4.31% | 6.12% | 4.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.08% | 0.71% | -18.67% | 20.54% | 18.64% |
| Operating Income | -34.83% | -35.90% | 12.32% | 17.86% | 19.15% |
| Income Before Tax | -3.61% | -4.43% | 44.24% | 18.94% | 20.22% |
| Income Tax Expenses | -666.29% | -672.93% | 98.14% | -128.11% | -124.52% |
| Earnings from Continuing Operations | -1.21% | -2.02% | 37.73% | 24.37% | 25.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 64.98% | 66.29% | -14.87% | -23.73% | -24.94% |
| Net Income | 33.96% | 33.43% | 45.76% | 25.19% | 26.37% |
| EBIT | -34.83% | -35.90% | 12.32% | 17.86% | 19.15% |
| EBITDA | -45.02% | -48.49% | 14.37% | 27.57% | 28.71% |
| EPS Basic | 33.96% | 33.43% | 45.76% | 25.19% | 26.37% |
| Normalized Basic EPS | 75.81% | 75.62% | -49.42% | -- | -- |
| EPS Diluted | 33.86% | 33.33% | 45.71% | 25.19% | 26.37% |
| Normalized Diluted EPS | 75.81% | 75.62% | -49.42% | -- | -- |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |